| References |
Akunne, H.C., Reid, A.A., Thurkauf, A., Jacobson, A.E., de Costa, B.R., Rice, K.C., Heyes, M.P., Rothman, R.B., [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex (1991) Synapse, 8, pp. 289-300; Browne, R.G., Welch, W.M., Stereoselective antagonism of phencyclidine's discriminative properties by adenosine receptor agonists (1982) Science, 217, pp. 1157-1159; Cachat, J., Kyzar, E.J., Collins, C., Gaikwad, S., Green, J., Roth, A., El-Ounsi, M., Kalueff, A.V., Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research (2013) Behav. Brain Res., 236, pp. 258-269; Chapman, A.G., Meldrum, B.S., Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice (1989) Eur. J. Pharmacol., 166, pp. 201-211; Chen, G., Bohner, B., Surgical anesthesia in the rabbit with 2-(ethylamino)-2-(2-thienyl) cyclohexanone-HCl (CI-634) and chloral hydrate (1968) Am. J. Vet. Res., 29, pp. 869-875; Chen, G., Ensor, C.R., 2-(ethylamino)-2-(2-thienyl) cyclohexanone-HCl (CI-634): a taming, incapacitating, and anesthetic agent for the cat (1968) Am. J. Vet. Res., 29, pp. 863-867; Chen, G., Ensor, C.R., Bohner, B., The pharmacology of 2-(ethylamino)-2-(2-thienyl)-cyclohexanone-HCl (CI-634) (1969) J. Pharmacol. Exp. Ther., 168, pp. 171-179; Cistola, A.M., Golder, F.J., Centonze, L.A., McKay, L.W., Levy, J.K., Anesthetic and physiologic effects of tiletamine, zolazepam, ketamine, and xylazine combination (TKX) in feral cats undergoing surgical sterilization (2004) Journal of Feline Medicine and Surgery, 6, pp. 297-303; de la Pena, J.B., Lee, H.C., de la Pena, I.C., Woo, T.S., Yoon, S.Y., Lee, H.L., Han, J.S., Cheong, J.H., Rewarding and reinforcing effects of the NMDA receptor antagonist-benzodiazepine combination, zoletil(R): difference between acute and repeated exposure (2012) Behav. Brain Res., 233, pp. 434-442; de la Pena, J.B., Yoon, S.Y., de la Pena, I.C., Lee, H.L., de la Pena, I.J., Cheong, J.H., Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, zoletil (2013) Behav. Pharmacol., 24, pp. 20-28; Doerning, B.J., Brammer, D.W., Chrisp, C.E., Rush, H.G., Nephrotoxicity of tiletamine in New Zealand white rabbits (1992) Lab. Anim. Sci., 42, pp. 267-269; Elfving, B., Bjornholm, B., Knudsen, G.M., Interference of anaesthetics with radioligand binding in neuroreceptor studies (2003) Eur. J. Nucl. Med. Mol. Imaging, 30, pp. 912-915; Kalueff, A.V., Gebhardt, M., Stewart, A.M., Cachat, J.M., Brimmer, M., Chawla, J.S., Craddock, C., Zebrafish Neuroscience Research, Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond (2013) Zebrafish, 10, pp. 70-86; Kalueff, A.V., Echevarria, D.J., Stewart, A.M., Gaining translational momentum: more zebrafish models for neuroscience research (2014) Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 55, pp. 1-6; Kalueff, A.V., Echevarria, D.J., Homechaudhuri, S., Stewart, A.M., Collier, A.D., Kaluyeva, A.A., Li, S., International Zebrafish Neuroscience Research Consortium, Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research (2016) Aquat. Toxicol., 170, pp. 297-309; Klockgether, T., Turski, L., Schwarz, M., Sontag, K.H., Lehmann, J., Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine (1988) Brain Res., 461, pp. 343-348; Kumar, A., Mann, H.J., Remmel, R.P., Pharmacokinetics of tiletamine and zolazepam (telazol((R))) in anesthetized pigs (2006) J. Vet. Pharmacol. Ther., 29, pp. 587-589; Kumar, A., Mann, H.J., Remmel, R.P., Beilman, G.J., Kaila, N., Pharmacokinetic study in pigs and in vitro metabolic characterization in pig- and human-liver microsomes reveal marked differences in disposition and metabolism of tiletamine and zolazepam (telazol) (2014) Xenobiotica, 44, pp. 379-390; Kyzar, E.J., Kalueff, A.V., Exploring hallucinogen pharmacology and psychedelic medicine with zebrafish models (2016) Zebrafish; Kyzar, E.J., Collins, C., Gaikwad, S., Green, J., Roth, A., Monnig, L., El-Ounsi, M., Kalueff, A.V., Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology (2012) Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 37, pp. 194-202; Morris, H., Wallach, J., From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs (2014) Drug Test Anal., 6, pp. 614-632; Neelkantan, N., Mikhaylova, A., Stewart, A.M., Arnold, R., Gjeloshi, V., Kondaveeti, D., Poudel, M.K., Kalueff, A.V., Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds (2013) ACS Chem. Neurosci., 4, pp. 1137-1150; Nguyen, M., Poudel, M.K., Stewart, A.M., Kalueff, A.V., Skin too thin? The developing utility of zebrafish skin (neuro) pharmacology for CNS drug discovery research (2013) Brain Res. Bull., 98, pp. 145-154; Olney, J.W., Labruyere, J., Price, M.T., Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs (1989) Science, 244, pp. 1360-1362; Quail, M.T., Weimersheimer, P., Woolf, A.D., Magnani, B., Abuse of telazol: an animal tranquilizer (2001) J. Toxicol-Clin. Toxic., 39, pp. 399-402; Rao, T.S., Contreras, P.C., Cler, J.A., Mick, S.J., Dilworth, V.M., Iyengar, S., Monahan, J.B., Wood, P.L., Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites (1991) J. Neurochem., 56, pp. 890-897; Rao, T.S., Contreras, P.C., Cler, J.A., Mick, S.J., Dilworth, V.M., Iyengar, S., Monahan, J.B., Wood, P.L., Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites (1991) J. Neurochem., 56, pp. 890-897; Rao, T.S., Contreras, P.C., Cler, J.A., Mick, S.J., Dilworth, V.M., Iyengar, S., Monahan, J.B., Wood, P.L., Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (Pcp) receptor ligand, with the N-methyl-D-aspartate-coupled and N-methyl-D-aspartate-uncoupled Pcp recognition sites (1991) J. Neurochem., 56, pp. 890-897; Riehl, R., Kyzar, E., Allain, A., Green, J., Hook, M., Monnig, L., Rhymes, K., Kalueff, A.V., Behavioral and physiological effects of acute ketamine exposure in adult zebrafish (2011) Neurotoxicol. Teratol., 33, pp. 658-667; Robinson, K.S., Stewart, A.M., Cachat, J., Landsman, S., Gebhardt, M., Kalueff, A.V., Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish (2013) Pharmacol. Biochem. Behav., 108, pp. 54-60; Stewart, A.M., Gerlai, R., Kalueff, A.V., Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery (2015) Front. Behav. Neurosci., 9, p. 14; Taylor, W.P., Reynolds, H.V., Ballard, W.B., Immobilization of grizzly bears with tiletamine hydrochloride and zolazepam hydrochloride (1989) J. Wildl. Manag., 53, pp. 978-981 |